EASYNAC-SP

Home
Products
EASYNAC-SP
EASYNAC - SP Product Banner 524px x 531px - 1

EASYNAC-SP

Easynac SP is a pharmaceutical formulation designed to address pain and inflammation associated with bone and soft tissue injuries, as well as post-operative pain.

THERAPY AREA: Ortho/phy
FORM: Tablet
PACKAGING: 10 x 10 Tablets.

Category:

1. Aceclofenac (100mg):
Aceclofenac is a non-steroidal anti-inflammatory drug (NSAID) known for its analgesic and anti-inflammatory properties. In comparative studies, Aceclofenac has demonstrated a significant improvement in pain intensity when compared to diclofenac, another widely used NSAID. By inhibiting the synthesis of prostaglandins, Aceclofenac helps alleviate pain and reduce inflammation.
2. Paracetamol (325mg):
Paracetamol is a well-established analgesic and antipyretic agent. It works by inhibiting the production of prostaglandins in the central nervous system, leading to pain relief and reduced fever. The inclusion of Paracetamol in Easynac SP enhances the overall analgesic effects of Aceclofenac, providing a comprehensive approach to pain management.
3. Serratiopeptidase (15mg):
Serratiopeptidase is an enzyme known for its anti-inflammatory properties. It acts by breaking down and removing inflammatory byproducts, reducing inflammation, and promoting microcirculation. In the context of Easynac SP, Serratiopeptidase contributes to the reduction of inflammation associated with soft tissue injuries and post-operative conditions, aiding in the overall healing process.

Mode Of Action:

Aceclofenac: Inhibits the production of prostaglandins, reducing pain and inflammation.
Paracetamol: Acts centrally to block pain signals and reduce fever, complementing the analgesic effects of Aceclofenac.
Serratiopeptidase: Breaks down inflammatory byproducts, leading to a reduction in inflammation and improved microcirculation.

By combining these three active ingredients, Easynac SP offers a multi-faceted approach to pain relief and anti-inflammatory action, making it a comprehensive solution for individuals dealing with pain and inflammation associated with bone and soft tissue injuries or post-operative recovery.

Indications:

  • Pelvic Inflammation
  • Post- surgical pain

Dosage:

2 tablets daily or as prescribed by Physician.

Instructions for usage:

As directed by Physician

STORAGE:

  • Store in cool, dry & dark place.
  • Keep out of reach of children.

Contraindications:

  • Pregnancy & lactation.
  • Congestive heart failure.
  • Active peptic ulceration.
FAQ’s:
a

How does Aceclofenac differ from diclofenac in terms of pain relief?

Aceclofenac has shown significant improvement in pain intensity compared to diclofenac, a widely used NSAID. In comparative studies, Aceclofenac’s efficacy in alleviating pain and reducing inflammation has been demonstrated, making it a favorable choice for individuals seeking effective pain relief.

a

Is Easynac SP safe for use during pregnancy and lactation?

No, Easynac SP is contraindicated during pregnancy and lactation. It is important to avoid its use in these conditions. Pregnant or lactating individuals should consult their healthcare provider for alternative pain management options that are safe during these periods.

Composition

Each film coated tablet contains
Aceclofenac IP 100mg
Paracetamol IP 325mg
Serratiopeptidase IP 15mg

Resources

Related products

No products in the cart.

test

Download

Kindly fill in your details. All fields mandatory.

    Download

    Kindly fill in your details. All fields mandatory.

      Raajesh Dhuria

      “To serve people with the highest quality healthcare solutions, and to do so through a brand they can always rely on for a healthier, happier lifestyle; because I believe there is no happiness without good health.” This is the simple, yet extraordinary vision of Mr Raajesh Dhuria, MD and CEO, a pharmaceutical leader with over three decades of experience not only in scaling up existing businesses in Multinational & Indian healthcare organisations but also creating new profitable ventures. A keen eye for identifying latest trends and driving teams with passion to create profitable brands and business is what distinguishes him from his peers. Having begun his career in the late 1980s, with Johnson & Johnson, Mr Dhuria up skilled himself quickly rose through his career to become a Sales Head in companies like Morepen labs & Cadila Pharmaceuticals in about a decade and a half. For many this would have been a big rise from a Medical representative to a sales head, but the hunger for doing things differently pushed him to do what very few people could achieve at that time- launch a pharmaceutical company. In 2003, Mr Dhuria launched Kinedex Healthcare Pvt. Ltd. He was responsible for the tremendous rise and success of the company over 15 years, including the popularity of the highly recommended brand for arthritis, Rosiflex. In 2019, the company was acquired by Eris pharmaceuticals, following which Mr Dhuria helped establish Novelty Healthshine and is now investing his time helping it reach even greater success. He sees the company as a listed one in another 5 years and at par with leading pharma companies. Mr Raajesh, is a self-motivated person and as any motivated person, he has a knack of developing talent by giving freedom of expression and ideas. He is highly receptive for innovating ideas and strategies to grow business and has a very strong appetite for novel ways to work. He has an extremely competent & committed team at work which is continuously working on delivering novel patient centric solutions & yes, a healthier and happier lifestyle.

      Raakesh Dhuria

      Raakesh is a very enthusiastic and energetic person with a perseverant nature. No wonder then, that he is an excellent leader guiding the field force at Novelty towards surpassing their goals year after year. Raakesh is one of the founder promoter Directors of Novelty HealthShine and has been associated with it since its inception. With his 30+ years of experience in Pharmaceutical selling he has risen from the ranks of a Medical representative to being a Director currently. Beginning his career at Lupin Laboratories, Raakesh has moved on to CFL as a frontline manager, followed by Morepen Laboratories. He embarked on his entrepreneurial journey beginning with Kinedex Healthcare and now at Novelty HealthShine. He has wide experience in selling brands of various therapeutic categories and supervising and motivating field force across the country. Raakesh is a Science Graduate with Masters in Business Administration and is passionate about keeping himself up-to-date with the latest in the field of medical and pharmaceutical research.

      Abhijit Singh

      Abhijit Singh is a seasoned Pharma leader who has front led Brand building, Business transformation & turnaround initiatives. With more than 2 decades of experience majorly in leadership positions at Zydus & Torrent - he is associated with popular brands with extensive work in Gastroenterology therapeutic area. A product innovator and a strategic thinker, he is constantly in pursuit of excellence in marketing and bringing about innovation to the customers. As an Executive Director at Novelty health shine, he is nurturing a multi-therapy product line with a focus on Nutrition. His role here is to bring innovation and carve a strategic charter to help the brands scale rapidly. Abhijit holds a Bachelor’s degree in Biochemistry and a Masters in Business Administration.

      Download Brochure

      Kindly fill in your details. All fields mandatory.